143 related articles for article (PubMed ID: 38426659)
1. Sphingomyelinase-responsive nanomicelles for targeting atherosclerosis.
Muñoz-Hernando M; Nogales P; Fernández-Barahona I; Ruiz-Cabello J; Bentzon JF; Herranz F
Nanoscale; 2024 Mar; 16(13):6477-6487. PubMed ID: 38426659
[TBL] [Abstract][Full Text] [Related]
2. Hybrid, metal oxide-peptide amphiphile micelles for molecular magnetic resonance imaging of atherosclerosis.
Poon C; Gallo J; Joo J; Chang T; Bañobre-López M; Chung EJ
J Nanobiotechnology; 2018 Nov; 16(1):92. PubMed ID: 30442135
[TBL] [Abstract][Full Text] [Related]
3. Nanoparticles targeting extra domain B of fibronectin-specific to the atherosclerotic lesion types III, IV, and V-enhance plaque detection and cargo delivery.
Yu M; Ortega CA; Si K; Molinaro R; Schoen FJ; Leitao RFC; Xu X; Mahmoudi M; Ahn S; Liu J; Saw PE; Lee IH; Brayner MMB; Lotfi A; Shi J; Libby P; Jon S; Farokhzad OC
Theranostics; 2018; 8(21):6008-6024. PubMed ID: 30613278
[TBL] [Abstract][Full Text] [Related]
4. Dual-modality Imaging of Angiogenesis in Unstable Atherosclerotic Plaques with VEGFR2-Targeted Upconversion Nanoprobes in vivo.
Fang Y; Yang R; Hou Y; Wang Y; Yang N; Xu M; Li S; Gao S; Jiang M; Fan J; Hu Y; Xu Z; Gao L; Cao F
Mol Imaging Biol; 2022 Oct; 24(5):721-731. PubMed ID: 35604528
[TBL] [Abstract][Full Text] [Related]
5. Engineering molecular nanoprobes to target early atherosclerosis: Precise diagnostic tools and promising therapeutic carriers.
Zan C; An J; Wu Z; Li S
Nanotheranostics; 2023; 7(3):327-344. PubMed ID: 37064609
[TBL] [Abstract][Full Text] [Related]
6. Accumulation of Iron Oxide-Based Contrast Agents in Rabbit Atherosclerotic Plaques in Relation to Plaque Age and Vulnerability Features.
Sekita A; Unterweger H; Berg S; Ohlmeyer S; Bäuerle T; Zheng KH; Coolen BF; Nederveen AJ; Cabella C; Rossi S; Stroes ESG; Alexiou C; Lyer S; Cicha I
Int J Nanomedicine; 2024; 19():1645-1666. PubMed ID: 38406599
[TBL] [Abstract][Full Text] [Related]
7. Improved in vivo detection of atherosclerotic plaques with a tissue factor-targeting magnetic nanoprobe.
Wei Q; Wang J; Shi W; Zhang B; Jiang H; Du M; Mei H; Hu Y
Acta Biomater; 2019 May; 90():324-336. PubMed ID: 30954623
[TBL] [Abstract][Full Text] [Related]
8. Microdistribution of Magnetic Resonance Imaging Contrast Agents in Atherosclerotic Plaques Determined by LA-ICP-MS and SR-μXRF Imaging.
Uca YO; Hallmann D; Hesse B; Seim C; Stolzenburg N; Pietsch H; Schnorr J; Taupitz M
Mol Imaging Biol; 2021 Jun; 23(3):382-393. PubMed ID: 33289060
[TBL] [Abstract][Full Text] [Related]
9. Imaging of the vulnerable carotid plaque: biological targeting of inflammation in atherosclerosis using iron oxide particles and MRI.
Chan JM; Monaco C; Wylezinska-Arridge M; Tremoleda JL; Gibbs RG
Eur J Vasc Endovasc Surg; 2014 May; 47(5):462-9. PubMed ID: 24594295
[TBL] [Abstract][Full Text] [Related]
10. Targeted Molecular Iron Oxide Contrast Agents for Imaging Atherosclerotic Plaque.
Evans RJ; Lavin B; Phinikaridou A; Chooi KY; Mohri Z; Wong E; Boyle JJ; Krams R; Botnar R; Long NJ
Nanotheranostics; 2020; 4(4):184-194. PubMed ID: 32637296
[No Abstract] [Full Text] [Related]
11. CD40-targeting magnetic nanoparticles for MRI/optical dual-modality molecular imaging of vulnerable atherosclerotic plaques.
Wu Q; Pan W; Wu G; Wu F; Guo Y; Zhang X
Atherosclerosis; 2023 Mar; 369():17-26. PubMed ID: 36863196
[TBL] [Abstract][Full Text] [Related]
12. Macrophage-targeted nanomedicine for the diagnosis and treatment of atherosclerosis.
Chen W; Schilperoort M; Cao Y; Shi J; Tabas I; Tao W
Nat Rev Cardiol; 2022 Apr; 19(4):228-249. PubMed ID: 34759324
[TBL] [Abstract][Full Text] [Related]
13. Histological validation of iron-oxide and gadolinium based MRI contrast agents in experimental atherosclerosis: the do's and don't's.
den Adel B; Bovens SM; te Boekhorst B; Strijkers GJ; Poelmann RE; van der Weerd L; Pasterkamp G
Atherosclerosis; 2012 Dec; 225(2):274-80. PubMed ID: 22882907
[TBL] [Abstract][Full Text] [Related]
14. Magnetic resonance imaging contrast-enhancement with superparamagnetic iron oxide nanoparticles amplifies macrophage foam cell apoptosis in human and murine atherosclerosis.
Segers FME; Ruder AV; Westra MM; Lammers T; Dadfar SM; Roemhild K; Lam TS; Kooi ME; Cleutjens KBJM; Verheyen FK; Schurink GWH; Haenen GR; van Berkel TJC; Bot I; Halvorsen B; Sluimer JC; Biessen EAL
Cardiovasc Res; 2023 Jan; 118(17):3346-3359. PubMed ID: 35325057
[TBL] [Abstract][Full Text] [Related]
15. Molecular imaging of atherosclerosis with nanoparticle-based fluorinated MRI contrast agents.
Palekar RU; Jallouk AP; Lanza GM; Pan H; Wickline SA
Nanomedicine (Lond); 2015; 10(11):1817-32. PubMed ID: 26080701
[TBL] [Abstract][Full Text] [Related]
16. Highly sensitive magnetic particle imaging of vulnerable atherosclerotic plaque with active myeloperoxidase-targeted nanoparticles.
Tong W; Hui H; Shang W; Zhang Y; Tian F; Ma Q; Yang X; Tian J; Chen Y
Theranostics; 2021; 11(2):506-521. PubMed ID: 33391489
[TBL] [Abstract][Full Text] [Related]
17. Activatable fluorescence imaging of macrophages in atherosclerotic plaques using iron oxide nanoparticles conjugated with indocyanine green.
Ikeda H; Ishii A; Sano K; Chihara H; Arai D; Abekura Y; Nishi H; Ono M; Saji H; Miyamoto S
Atherosclerosis; 2018 Aug; 275():1-10. PubMed ID: 29852399
[TBL] [Abstract][Full Text] [Related]
18. In vivo MRI detection of atherosclerosis in ApoE-deficient mice by using tenascin-C-targeted USPIO.
Li Y; Liu J; Huang JW; Song JC; Ma ZL; Shi HB
Acta Radiol; 2018 Dec; 59(12):1431-1437. PubMed ID: 29566551
[TBL] [Abstract][Full Text] [Related]
19. Hyaluronan Nanoparticles Selectively Target Plaque-Associated Macrophages and Improve Plaque Stability in Atherosclerosis.
Beldman TJ; Senders ML; Alaarg A; Pérez-Medina C; Tang J; Zhao Y; Fay F; Deichmöller J; Born B; Desclos E; van der Wel NN; Hoebe RA; Kohen F; Kartvelishvily E; Neeman M; Reiner T; Calcagno C; Fayad ZA; de Winther MPJ; Lutgens E; Mulder WJM; Kluza E
ACS Nano; 2017 Jun; 11(6):5785-5799. PubMed ID: 28463501
[TBL] [Abstract][Full Text] [Related]
20. A Comparative Study of Ultrasmall Calcium Carbonate Nanoparticles for Targeting and Imaging Atherosclerotic Plaque.
Martínez-Parra L; Piñol-Cancer M; Sanchez-Cano C; Miguel-Coello AB; Di Silvio D; Gomez AM; Uriel C; Plaza-García S; Gallego M; Pazos R; Groult H; Jeannin M; Geraki K; Fernández-Méndez L; Urkola-Arsuaga A; Sánchez-Guisado MJ; Carrillo-Romero J; Parak WJ; Prato M; Herranz F; Ruiz-Cabello J; Carregal-Romero S
ACS Nano; 2023 Jul; 17(14):13811-13825. PubMed ID: 37399106
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
